← Eichor
Study identifier: NCT07688902 Synced from ClinicalTrials.gov · July 28, 2026
● Recruiting

Intralesional Versus Perilesional 5% Dextrose Injection in Partial Rotator Cuff Tears

Condition: Partial Rotator Cuff Tears · Rotator Cuff Tendinopathy · Shoulder Pain Chronic  ·  Sponsor: Ankara City Hospital Bilkent

PhaseNA
Planned participants30
Who can joinAll sexes, 18 Years to 75 Years
Healthy volunteersNo

About this study

This prospective, randomized, double-blind controlled clinical trial aims to compare the clinical and ultrasonographic outcomes of intralesional and perilesional 5% dextrose injection in patients with partial rotator cuff tears. Eligible participants will be randomized into two parallel groups. Both groups will receive ultrasound-guided 5% dextrose injection to the supraspinatus enthesis. In addition, one group will receive intralesional 5% dextrose injection, while the other group will receive perilesional 5% dextrose injection using the peppering technique. Injections will be performed in three treatment sessions at 21-day intervals. All participants will receive a home-based exercise program after completion of the injection treatments. Clinical outcomes will be assessed at baseline, 9 weeks, and 12 weeks after treatment, and ultrasonographic outcomes will be assessed at baseline and 12 weeks.

This description comes directly from the study's public registry record.

Talk to the study team

Esra Ülgen Kıratlıoğlu, MD  ·  +905079614194  ·  esraulgen@gmail.com

Always discuss trial participation with your own doctor first.

Locations (1)

Ankara Bilkent City Hospital, Physical Medicine and Rehabilitation HospitalAnkara, Turkey (Türkiye)Recruiting

Follow this study

Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.

We email about this public record only. Unsubscribe anytime with one click. Never medical advice.

Is this your study? This page was generated automatically from the public registry record. Sponsors can claim it — free — to add branding and verified contact routing. Claim this page →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.

Source record: clinicaltrials.gov/study/NCT07688902